Quantcast

LEGAL NEWSLINE

Thursday, September 19, 2024

Idaho Attorney General announces consent decree with northern hospitals

State AG
Webp vu5wzlb9znfxwayir8fp5dm67fnz

Attorney General Raúl Labrador | Official Website

Attorney General Raúl Labrador has announced a Consent Decree to conclude his investigation into potential violations of Idaho’s antitrust law, the Idaho Competition Act, by Kootenai Health in Coeur d’Alene and Syringa Hospital and Clinics in Grangeville. The Attorney General's office initiated the investigation in 2023, working alongside the Federal Trade Commission.

“My office is concerned about the trend of consolidation within healthcare markets in Idaho,” said Attorney General Labrador. “We are committed to enforcing the laws that protect and promote fair competition in Idaho and we are pleased that we reached a resolution addressing our current concerns.”

In 2017, Kootenai Health and Syringa entered into a management agreement whereby Kootenai Health hired and paid for Syringa’s CEO, thereby making the Syringa CEO an employee of Kootenai Health. As a result of this agreement, Kootenai Health gained access to Syringa’s significant competitively sensitive non-public information.

Then in 2020, Kootenai Health acquired St. Mary’s Health (in Cottonwood) and Clearwater Valley Hospital (in Orofino) from their out-of-state owner. St. Mary’s Hospital, located approximately 15 miles away, is Syringa’s nearest hospital competitor. After this acquisition, Kootenai Health owned or had a substantial relationship with the only two hospitals in Idaho County.

The investigation discovered that as a result of this relationship between St. Mary’s and Syringa, the hospitals may have engaged in conduct that violates the Idaho Competition Act. During the investigation, Kootenai Health and Syringa agreed to terminate the management agreement and at the direction of the Attorney General, sign a Consent Decree to provide further protections against potential future violations of the Idaho Competition Act.

The Consent Decree mandates that Kootenai Health terminate its employment of Syringa’s CEO; the hospitals terminate all existing agreements, contracts, arrangements, collaborations, or affiliations between them, except where the Attorney General does not object; and in the future, the hospitals provide notice to the Attorney General of any proposed agreements, contracts, arrangements, collaborations, or affiliations between them.

The Consent Decree also prohibits any agreements between the hospitals limiting competition for labor and the exchange of non-public labor information such as compensation and terms of employment. The Consent Decree has been approved by the Court.

ORGANIZATIONS IN THIS STORY

More News